Experience with moricizine HCl in children with supraventricular tachycardia

International Journal of Cardiology

Volumn 57, Issue 1, 1996, Pages 31-35

  Mehta, Ashok V ^a   Subrahmanyam, Arumughakumari B ^a   Long, J Blake ^b   Kanter, Ronald J ^b  

^a East Tennessee State University   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atrial ectopictachycardia; Junctional ectopic tachycardia; Moricizine; Supraventricular tachycardia in children

Indexed keywords

MORACIZINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA;

ADOLESCENT; ADULT; ANTI-ARRHYTHMIA AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MORICIZINE; RETROSPECTIVE STUDIES; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME;

EID: 0030589105     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(96)02763-5     Document Type: Article

References (15)

1. [1] Dorian P, Echt DS, Mead RH, Lee JT, Lebsack CS, Winkle RA. Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias. Am Heart J 1986; 112: 327-333.
2. [2] Mahler SA, Borland RM. Clinical development of moricizine as an antiarrhythmic agent. Am J Cardiol 1990; 65: 11D-14D.
3. [3] Fitton A, Buckley MMT. Moricizine: a review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias. Drugs 1990; 40(1): 138-167.
4. [4] Chazov EI, Shugushev KK, Rosenshtraukh LV. Ethmozin. I. Effects of intravenous drug administration on paroxysmal supraventricular tachycardia in the ventricular preexcitation syndrome. Am Heart J 1984; 108: 475-482.
5. [5] Chazov EI, Rosenshtraukh LV, Shugushev KK. Ethmozin. II. Effects of intravenous drug administration on atrioventricular nodal reentrant tachycardia. Am Heart J 1984; 108: 483-489.
6. [6] Dangman Kh, Hoffman BF. Antiarrhythmic effects of ethmozin in cardiac Purkinje fibers: suppression of automaticity and abolition of triggering. J Pharmocol Exp Ther 1983; 227(3): 578-586.
7. [7] Bigger JT Jr. Cardiac electrophysiologic effects of moricizine hydrochloride. Am J Cardiol 1990; 65: 15D-20D.
8. [8] Evans VL, Garson A Jr., Smith RT, Moak JP, McVey P, McNamara DG. Ethmozine (moricizine HCl): a promising drug for 'automatic' atrial ectopic tachycardia. Am J Cardiol 1987; 60: 83F-86F.
9. [9] Moak JP, Smith RT, Garson A Jr. Newer antiarrhythmic drugs in children. Am Heart J 1987; 113: 179-185.
10. [10] Ludomirsky A, Garson A Jr. Supraventricular tachycardia. In: Gillette PC and Garson A Jr., eds. Pediatric arrhythmias: electrophysiology and pacing. Philadelphia, PA: W.B. Saunders, 1990; 380-426.
11. [11] Mehta AV, Sanchez GR, Sacks EJ, Casta A, Dunn JM, Donner RM. Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up. J Am Coll Cardiol 1988; 11: 379-385.
12. [12] Paul T, Reimer A, Janousek J, Kallfelz HC. Efficacy and safety of propafenone in congenital junctional ectopic tachycardia. J Am Coll Cardiol 1992; 20: 911-914.
13. [13] Young ML, Mehta MB, Martinez RM, Wolff GS, Gelband H. Combined alpha-adrenergic blockade and radiofrequency ablation to treat junctional ectopic tachycardia successfully without atrioventricular block. Am J Cardiol 1993; 71: 883-885.
14. [14] Schienman MM, Gonzalez RP, Cooper MW, Lesh MD, Lee RJ, Epstein LM. Clinical and electrophysiologic features and role of catheter ablation techniques in adult patients with automatic atrioventricular junctional tachycardia. Am J Cardiol 1994; 74: 565-572.
15. [15] Kennedy HL. Noncardiac adverse effects and organ toxicity of moricizine during short-and long-term studies. Am J Cardiol 1990; 65: 47D-50D.